NCT07385950 2026-02-04
Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors
Zhongnan Hospital
Not yet recruiting
Clinical Trials
10 trialsNCT07306338 2025-12-29
Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment
University of Southern California
Not yet recruiting
NCT07046780 2025-07-02
A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06755086 2025-01-01
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06719856 2024-12-27
MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06720298 2024-12-27
CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06090513 2024-08-06
Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients
Bien-Willner Physicians Group PA
Not yet recruiting
NCT06298773 2024-03-07
PROST
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT05819580 2023-04-25
Studying the Clinical Trial Experiences of Patients With Mesothelioma
Power Life Sciences Inc.
Not yet recruiting
NCT05645094 2022-12-13
Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer
Fudan University
Not yet recruiting